Exact Mass: 259.9566

Exact Mass Matches: 259.9566

Found 220 metabolites which its exact mass value is equals to given mass value 259.9566, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Methazole

2-(3,4-Dichlorophenyl)- 4-methyl-1,2,4-oxadiazolidine-3,5-dione

C9H6Cl2N2O3 (259.9755)

Caffeic acid 4-O-sulfate

(2E)-3-[3-Hydroxy-4-(sulphooxy)phenyl]prop-2-enoic acid

C9H8O7S (259.9991)

Caffeic acid 4-sulfate, also known as caffeate 4-sulphate or caffeic acid 4-sulphuric acid, is a member of the class of compounds known as hydroxycinnamic acids. Hydroxycinnamic acids are compounds containing an cinnamic acid where the benzene ring is hydroxylated. Caffeic acid 4-sulfate is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa). Caffeic acid 4-sulfate can be found primarily in blood and urine. Within the cell, caffeic acid 4-sulfate is primarily located in the cytoplasm. It can also be found in the extracellular space. Caffeic acid 4-O-sulfate (CAS: 1213651-94-5) is a polyphenol metabolite detected in biological fluids (PMID: 20428313). Caffeic acid sulfate was found to be elevated in rat urine after whole rye consumption which makes this compound a potential urinary biomarker of whole grain intake (PMID: 26862900).

Caffeic acid 3-O-sulfate

(2E)-3-[4-Hydroxy-3-(sulfooxy)phenyl]-2-propenoic acid

C9H8O7S (259.9991)

Caffeic acid 3-O-sulfate (CAS: 1208232-16-9) is a polyphenol metabolite detected in biological fluids (PMID: 20428313). Caffeic acid sulfate was found to be elevated in rat urine after whole rye consumption which makes this compound a potential urinary biomarker of whole grain intake (PMID: 26862900).

3,5-Dihydroxycinnamic acid sulfate

(2E)-3-[3-Hydroxy-5-(sulphooxy)phenyl]prop-2-enoic acid

C9H8O7S (259.9991)

Caffeic acid 3-sulfate

(2E)-3-[4-hydroxy-3-(sulfooxy)phenyl]prop-2-enoic acid

C9H8O7S (259.9991)

An aryl sulfate that is trans-caffeic acid in which the phenolic hydrogen at position 3 is replaced by a sulfo group. A metabolite from coffee.

Caffeic acid 4-sulfate

(2E)-3-[3-hydroxy-4-(sulfooxy)phenyl]prop-2-enoic acid

C9H8O7S (259.9991)

4,4,4-Trifluorobutyl trifluoromethanesulfonate

C5H6F6O3S (259.9942)

2,6-dichloro-3-nitro-5-(trifluoromethyl)pyridine

C6HCl2F3N2O2 (259.9367)

5-(3,5-DICHLOROPHENYL)-5-OXOVALERIC ACID

C11H10Cl2O3 (260.0007)

1-(4-BROMOPHENYL)-4-CHLOROBUTAN-1-ONE

C10H10BrClO (259.9604)

3-Bromobenzophenone

C13H9BrO (259.9837)

1-Iodo-4-(2-methyl-2-propanyl)benzene

C10H13I (260.0062)

4-(2-bromophenyl)butanoyl chloride

C10H10BrClO (259.9604)

1-chloro-7-iodoheptane

C7H14ClI (259.9829)

1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarbonyl chloride

C11H7ClF2O3 (260.0052)

3-chloro-2-fluoro-6-(trifluoromethyl)benzoyl chloride

C8H2Cl2F4O (259.9419)

2,3-DIHYDRO-3-(IODOMETHYL)-BENZOFURAN

C9H9IO (259.9698)

4-CHLORO-3,5-DINITROPHENYLACETIC ACID

C8H5ClN2O6 (259.9836)

2-Bromo-4,5-dimethoxybenzoic acid

C9H9BrO4 (259.9684)

Propane,1,1,1,2,2-pentafluoro-3-iodo-

C3H2F5I (259.9121)

5-Bromo-2,4-dimethoxybenzoic acid

C9H9BrO4 (259.9684)

Ethyl bromo(4-fluorophenyl)acetate

C10H10BrFO2 (259.9848)

Bismuth(3+) trihydroxide

BiH3O3 (259.9886)

1-((4-BROMOTHIOPHEN-2-YL)METHYL)PIPERAZINE

C9H13BrN2S (259.9983)

Methyl 6-bromo-5-nitronicotinate

C7H5BrN2O4 (259.9433)

6-Iodo-3-Benzofuranone

C8H5IO2 (259.9334)

2,3-bis(2-sulfanylethylsulfanyl)propane-1-thiol

C7H16S5 (259.9856)

carbarsone

C7H9AsN2O4 (259.9778)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

2-Bromo-4,5-dinitrotoluene

C7H5BrN2O4 (259.9433)

TRIMETHYL 4-BROMOORTHOBENZOATE

C10H13BrO3 (260.0048)

4-(1,2,3-THIADIAZOL-4-YL)BENZENESULFONYLCHLORIDE

C8H5ClN2O2S2 (259.9481)

1-(4-iodophenyl)butane

C10H13I (260.0062)

3-Bromo-4-hydroxy-5-methoxyphenylacetic acid

C9H9BrO4 (259.9684)

2-Bromobenzophenone

C13H9BrO (259.9837)

3-Iodo-2-methoxyisonicotinonitrile

C7H5IN2O (259.9447)

2,4-DINITRO BENZYL BROMIDE

C7H5BrN2O4 (259.9433)

4-Bromo-[1,1-biphenyl]-4-carboxaldehyde

C13H9BrO (259.9837)

sodium,1,4-dioxonaphthalene-2-sulfonate

C10H5NaO5S (259.9755)

3,6-dichloro-1-benzothiophene-2-carbohydrazide

C9H6Cl2N2OS (259.9578)

1-bromo-5-methyl-2,4-dinitro-benzene

C7H5BrN2O4 (259.9433)

4-IODOBENZOFURAN-3(2H)-ONE

C8H5IO2 (259.9334)

5-Chloronaphthalene-2-sulfonyl Chloride

C10H6Cl2O2S (259.9466)

3-(2-Iodophenyl)propanal

C9H9IO (259.9698)

6-IODO-3H-ISOBENZOFURAN-1-ONE

C8H5IO2 (259.9334)

ethyl 2-broMo-2-(2-fluorophenyl)acetate

C10H10BrFO2 (259.9848)

Chloro(dimethyl)(pentafluorophenyl)silane

C8H6ClF5Si (259.9847)

2-[(4-Bromo-2-nitrophenyl)amino]ethanol

C8H9BrN2O3 (259.9797)

Sulfonium,dimethyl(2-oxo-2-phenylethyl)-, bromide (1:1)

C10H13BrOS (259.987)

2,3,5,6-Tetramethyliodobenzene

C10H13I (260.0062)

4-Bromobenzophenone

C13H9BrO (259.9837)

trimorphamid

C7H11Cl3N2O2 (259.9886)

1-IODO-3-TERT-BUTYLBENZENE

C10H13I (260.0062)

chloromethanone,gold(1+)

CAuClO (259.9303)

6-Bromo-2,3-dimethoxybenzoic acid

C9H9BrO4 (259.9684)

3-CHLORO-4-[(CHLOROACETYL)AMINO]PHENYL THIOCYANATE

C9H6Cl2N2OS (259.9578)

(4-BROMO-2-BUTENYL)TRIPHENYLPHOSPHONIUMBROMIDE

C9H9BrO2S (259.9507)

3-bromo-2,6-dimethoxybenzoic acid

C9H9BrO4 (259.9684)

Methyl 5-bromo-2-(methylthio)benzoate

C9H9BrO2S (259.9507)

BIS(2 2 2-TRIFLUOROETHYL)METHYLPHOSPHON&

C5H7F6O3P (260.0037)

2,4-bis(trifluoromethyl)pyrimidine-5-carboxylic acid

C7H2F6N2O2 (260.002)

4-(3-BROMO-2-THIENYL)-1,3-THIAZOL-2-AMINE

C7H5BrN2S2 (259.9078)

1-Naphthalenesulfonylchloride, 5-chloro-

C10H6Cl2O2S (259.9466)

2-Chlorophenyl Trifluoromethanesulfonate

C7H4ClF3O3S (259.9522)

1-Bromo-2-methyl-3,5-dinitrobenzene

C7H5BrN2O4 (259.9433)

Benzene,2-(2-bromoethoxy)-1,3-dimethoxy-

C10H13BrO3 (260.0048)

4-Iodo-5-methoxynicotinonitrile

C7H5IN2O (259.9447)

3-Chloro-5-(trifluoromethyl)pyridine-2-sulfonamide

C6H4ClF3N2O2S (259.9634)

5-BROMOMETHYL-1,2,3-TRIMETHOXY-BENZENE

C10H13BrO3 (260.0048)

4-fluorobenzylmagnesium chloride 0.25m&

C11H9BrMgO (259.9687)

(2E)-3-(4-Bromo-2-chlorophenyl)acrylic acid

C9H6BrClO2 (259.924)

4-bromo-2,5-dimethoxybenzoic acid

C9H9BrO4 (259.9684)

4,7-Dichloro-1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid

C9H2Cl2O5 (259.9279)

TRICARBONYL(NAPHTHALENE)CHROMIUM

C13H4CrO3 (259.9566)

3-(2,6-dichloropyridin-4-yl)-4-methyl-1H-1,2,4-triazole-5-thione

C8H6Cl2N4S (259.969)

3-(2-chloro-3,4-dimethoxyphenyl)prop-2-enoyl chloride

C11H10Cl2O3 (260.0007)

5-bromo-1,2-difluoro-3-(trifluoromethyl)benzene

C7H2BrF5 (259.926)

6-Quinoxalinecarbonylchloride, 2,3-dichloro-

C9H3Cl3N2O (259.9311)

2-bromo-4-chlorobutyrophenone

C10H10BrClO (259.9604)

ALLYLPALLADIUM(II) TRIFLUOROACETATE, DIMER

C5H5F3O2Pd (259.9276)

4-Bromo-1-methoxy-2-(2-methoxyethoxy)benzene

C10H13BrO3 (260.0048)

4-(AMINOSULFONYL)-5-CHLOROPHTHALIMIDE

C8H5ClN2O4S (259.9659)

2,4-Dichlorobenzenediazonium tetrafluoroborate

C6H3BCl2F4N2 (259.9702)

2-methyl-4-oxo-4-(3,4-dichlorophenyl)butyric acid

C11H10Cl2O3 (260.0007)

4-(Trifluoromethoxy)benzenesulfonyl chloride

C7H4ClF3O3S (259.9522)

Ethyl 3-(2,5-dichlorophenyl)-3-oxopropanoate

C11H10Cl2O3 (260.0007)

3-Iodo-1H-indazol-5-ol

C7H5IN2O (259.9447)

4-Iodo-1,2-dihydro-3H-indazol-3-one

C7H5IN2O (259.9447)

4-(2,2-DIMETHOXYETHOXY)BROMOBENZENE

C10H13BrO3 (260.0048)

6-Iodoimidazo[1,2-b]pyridazin-2-amine

C6H5IN4 (259.9559)

7-IODOBENZOFURAN-3(2H)-ONE

C8H5IO2 (259.9334)

methyl 4-chloro-2,6-dinitrobenzoate

C8H5ClN2O6 (259.9836)

5-BROMO-2,3-DIHYDROBENZO[B]FURAN-7-CARBONYL CHLORIDE

C9H6BrClO2 (259.924)

(E)-2-(2-TOSYLHYDRAZONO)ACETYL CHLORIDE

C9H9ClN2O3S (260.0022)

Folins reagent

C10H5NaO5S (259.9755)

4-(2,4-DICHLORO-PHENYL)-2,4-DIOXO-BUTYRIC ACID

C10H6Cl2O4 (259.9643)

6,8-DICHLORO-CHROMAN-3-CARBOXYLIC ACID METHYL ESTER

C11H10Cl2O3 (260.0007)

Acamprosate calcium

C5H10NO4S .1/2 Ca (259.9582)

Acamprosate calcium(Campral EC) is a GABA receptor agonist and modulator of glutamatergic systems; reduces alcohol consumption in animal models of alcohol addiction. IC50 value: Target: GABA receptor Acamprosate, or N-acetyl homotaurine, is an N-methyl-D-aspartate receptor modulator approved by the Food and Drug Administration (FDA) as a pharmacological treatment for alcohol dependence.Acamprosate has low bioavailability, but also has an excellent tolerability and safety profile. In comparison with naltrexone and disulfiram, which are the other FDA-approved treatments for alcohol dependence, acamprosate is unique in that it is not metabolized by the liver and is also not impacted by alcohol use, so can be administered to patients with hepatitis or liver disease (a common comorbid condition among individuals with alcohol dependence) and to patients who continue drinking alcohol.